CNTNAP2 — Contactin Associated Protein 2

Introduction

Cntnap2 — Contactin Associated Protein 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- ^{1Citation2024} title: CNTNAP2 Gene ^{2Citation2023} description: Contactin Associated Protein 2 gene implicated in neurodegenerative diseases ^{3Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.2023 · Hum Genet · DOI 10.1007/s00439-023-02552-2 · PMID 37183190Open reference} tags: gene, neurodegeneration ^{4CAR T cells produced in vivo to treat cardiac injury.2022 · Science · DOI 10.1126/science.abm0594 · PMID 34990237Open reference}

--- ^{5Citation2022}

.infobox.inbox-gene ^{6Citation2021} CNTNAP2 ^{7Citation2021} === === Full Name: Contactin Associated Protein 2 Chromosome: 7q35-q36.1 NCBI Gene ID: 26045 OMIM: 604569 Ensembl ID: ENSG00000198006 UniProt: O14520 === === Associated Diseases: Autism spectrum disorder, epilepsy, intellectual disability, Pitt-Hopkins syndrome, Alzheimer’s disease, Parkinson’s disease

Overview

Contactin Associated Protein 2 (CNTNAP2) is one of the largest genes in the human genome, encoding a massive cell adhesion molecule that belongs to the neurexin superfamily. CNTNAP2 is a transmembrane protein that functions as a synaptic organizer, mediating cell-cell interactions at synapses and playing critical roles in neuronal migration, synapse formation, circuit assembly, and neural network function. The gene is strongly associated with multiple neurodevelopmental disorders and is emerging as a point of convergence for understanding synaptic dysfunction in neurodegeneration.

Gene Structure

The CNTNAP2 gene spans approximately 2.3 Mb on chromosome 7q35-q36.1, making it one of the largest genes in the human genome. The gene contains 24 exons encoding a protein of 1,901 amino acids with a molecular weight of approximately 200 kDa. CNTNAP2 contains multiple protein domains including: (1) a signal peptide at the N-terminus; (2) multiple discoidin-like domains that mediate carbohydrate binding; (3) epidermal growth factor (EGF)-like repeats; (4) a transmembrane domain; and (5) a cytoplasmic C-terminal PDZ-binding motif. The gene undergoes extensive alternative splicing, producing multiple isoforms with distinct expression patterns and binding properties.

Protein Structure and Function

CNTNAP2 is a member of the neurexin family of cell adhesion molecules, but differs from classical neurexins in several important respects. Unlike neurexins, CNTNAP2 does not bind neuroligins and may signal through different pathways. The protein is localized to both presynaptic and postsynaptic membranes, where it functions as a bidirectional synaptic organizer.

The primary functions of CNTNAP2 include: (1) mediating synaptic adhesion—facilitates proper synapse formation and maintenance through homophilic and heterophilic interactions; (2) organizing synaptic protein complexes—recruits scaffolding proteins, receptors, and signaling molecules to synaptic contacts; (3) regulating neuronal migration—essential for correct neuronal positioning during cortical development; (4) facilitating circuit assembly—guides axons to appropriate targets and establishes specific connection patterns; (5) maintaining network stability—participates in homeostatic mechanisms that stabilize neural networks.

Expression Pattern

CNTNAP2 exhibits high expression during brain development, particularly in cortical GABAergic interneurons, layer V pyramidal neurons, and cerebellar Purkinje cells. In the adult brain, CNTNAP2 continues to be expressed at moderate levels in the cerebral cortex, hippocampus, basal ganglia, and cerebellum. The protein localizes to both presynaptic and postsynaptic compartments at excitatory and inhibitory synapses. CNTNAP2 expression is particularly high in brain regions involved in higher cognitive functions.

Role in Neurodegeneration

Alzheimer’s Disease: Emerging evidence suggests CNTNAP2 dysfunction may contribute to Alzheimer’s disease pathogenesis. The protein’s role in synaptic organization and GABAergic signaling may be relevant to early synaptic dysfunction in AD. Some studies have found altered CNTNAP2 expression in AD brain tissue.

Parkinson’s Disease: CNTNAP2 expression is altered in Parkinson’s disease models and may play roles in dopaminergic circuit function. The protein’s functions in synaptic plasticity may be relevant to disease progression.

Neurodevelopmental Disorders: CNTNAP2 is one of the most strongly associated genes with autism spectrum disorder, with recessive mutations causing cortical dysplasia-focal epilepsy (CDFE) syndrome. Heterozygous mutations and common variants are associated with autism, intellectual disability, and Pitt-Hopkins syndrome. The protein plays essential roles in GABAergic interneuron function, which is disrupted in many neurodevelopmental disorders.

Therapeutic Implications

CNTNAP2 represents a promising therapeutic target. Strategies under investigation include: (1) gene therapy to restore CNTNAP2 function; (2) small molecules that enhance CNTNAP2 expression or function; (3) modulation of downstream signaling pathways; (4) targeted interventions for specific disease manifestations.

Animal Models

Cntnap2 knockout mice exhibit: reduced exploratory behavior and social interaction; impaired vocalization; hyperactivity; seizures; cortical dysplasia; reduced GABAergic interneuron numbers; synaptic transmission deficits. These phenotypes closely model aspects of autism and epilepsy. Transgenic and rescue experiments have demonstrated partial reversal of phenotypes with CNTNAP2 expression restoration.

Key Publications

[1] https://pubmed.ncbi.nlm.nih.gov/11138004/ [2] https://pubmed.ncbi.nlm.nih.gov/11756681/ [3] https://pubmed.ncbi.nlm.nih.gov/12845676/ [4] https://pubmed.ncbi.nlm.nih.gov/15800063/ [5] https://pubmed.ncbi.nlm.nih.gov/16870176/ [6] https://pubmed.ncbi.nlm.nih.gov/17377532/ [7] https://pubmed.ncbi.nlm.nih.gov/18567533/ [8] https://pubmed.ncbi.nlm.nih.gov/19696938/

Pathway & Interaction Diagram

Interactive diagram showing CNTNAP2’s key relationships in the SciDEX knowledge graph (6 connections shown).

flowchart TD
    CNTNAP2(["CNTNAP2"])
    Autism["Autism"]
    Als["Als"]
    MMP9(["MMP9"])
    AND(["AND"])
    neurodegeneration["neurodegeneration"]

    CNTNAP2 -.->|"inhibits"| Autism
    CNTNAP2 -.->|"inhibits"| Als
    CNTNAP2 -.->|"inhibits"| MMP9
    CNTNAP2 -.->|"inhibits"| AND
    MMP9 -.->|"inhibits"| CNTNAP2
    CNTNAP2 -->|"implicated in"| neurodegeneration

    style CNTNAP2 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff

See Also

• Genes Index

• CNTNAP2 Protein

• Synaptic Plasticity Pathway

• Alzheimer’s Disease

• Parkinson’s Disease

• Autism Spectrum Disorder

• Epilepsy

External Links

• NCBI Gene

• UniProt

• Ensembl

• GeneCards

Background

The study of Cntnap2 — Contactin Associated Protein 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.